New Zealand Data Sheet - Medsafe
Clozapine is associated with an increased risk of myocarditis which has, in rare cases, been fatal. The increased risk of myocarditis is greatest in …
Tags:
Sheet, Data, Risks, Zealand, New zealand data sheet, Clozapine
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Clozapine and the Risk of Neutropenia
www.clozapinerems.comClozapine and the Risk of Neutropenia: A Guide for HealthcareProviders . This Guide discusses: •What is the Clozapine REMS Program? •Clozapine and the risk of severe neutropenia
Risks, Neutropenia, Clozapine, Clozapine and the risk of neutropenia, Clozapine and the risk of
A Guide for Patients and Caregivers - Clozapine …
www.clozapinerems.comA Guide for Patients and Caregivers: What You Need to Know about Clozapine and Neutropenia September 2015
Guide, Patients, Caregivers, Neutropenia, Clozapine, Guide for patients and caregivers
Anaesthesia and Psychiatric drugs (2) - FRCA
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com Cardiac risk Patients suffering from chronic schizophrenia have a …
Drug, Risks, Anaesthesia, Psychiatric, Anaesthesia and psychiatric drugs
CLINICAL PHARMACOLOGY NOTES potent - …
www.mrcpass.comMesalazine can cause neutropenia. It works in IBD by release in the terminal ileum. Mesalazine is given in the acute attacks in Crohn's disease. Sulfasalazine ...
Notes, Clinical, Pharmacology, Neutropenia, Clinical pharmacology notes
HIGHLIGHTS OF PRESCRIBING INFORMATION …
pp.jazzpharma.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FAZACLO safely and effectively. See …
Hematology review - Austin Community College
www.austincc.eduMorphologic approach Microcytic anemia – MCV < 80 fl Reduced iron availability —severe iron deficiency, the anemia of chronic disease, copper deficiency Reduced heme synthesis —lead poisoning, congenital or